International Hereditary Cancer Centre – selected
publications (updated in September 2005)
1993-1995
1.
2.
3.
4.
5.
6.
7.
Zajaczek S., Podolski J., Lubinski J., Roslawska A., Krzystolik Z., Sagan Z.:
RFLP-PCR in exclusion of Rb gene mutation carrier status; Klin. Ok 1993 ;
95: 216-218 (Polish).
Kostyk E., Wieckiewicz J., Jasinska A., Zygulska-Mach H., Pietrzyk J.,
Lubinski J., Zajaczek S., Podolski J.: Molecular analyses in families with
retinoblastoma. Nowotwory 1994; 44: supl.1, 57-61 (Polish).
Lubinski J., Hadaczek P., Podolski J., Toloczko A., Sikorski A., McCue P.,
Druck T., Huebner K.: Common regions of deletion in chromosome regions 3p
12 and 3p 14.2 in primary clear cell renal carcinomas. Cancer Research 1994;
54: 3710-3713.
Zajaczek S., Kladny J., Lubinski J.: Hereditary predisposition to tumours rules of diagnosis and management. Nowotwory 1994; 44: supl.1, 40-49
(Polish).
Druck T., Kastury K., Hadaczek P., Podolski J., Toloczko A., Ohta M.,
LaForgia S., Lasota J., McCue P., Lubinski J., Huebner K.: Loss of
heterozygosity at the familial RCC t(3;8) locus in most clear cell renal
carcinomas. Cancer Res.1995; 55: 5348-5353.
Kladny J., Lubinski J.: HNPCC frequency in registry of Regional Hereditary
Cancer Centre in Szczecin. Wybrane zagadnienia z chirurgii 1995; 255-258
(Polish).
Podolski J., Hadaczek P., Gibas L., Grossman B.H., Limon J., Huebner K.,
Lubinski J.: Non-isotopic procedure with silver staning of polyacrylamide gels
in detection of genomic abnormalities in tumours using microsatellites; Folia
Histochemica et Cytobiologica 1995; 33: 117-123.
1996
8.
Hadaczek P., Podolski J., Toloczko A., Kurzawski G., Sikorski A., Huebner K.,
Rabbitts P., Lubinski J.: Losses at 3p common deletion sites in subtypes of
kidney tumours: histopathological correlations. Virchows Arch. 1996; 429: 3742.
9. Kladny J., Kurzawski G., Lubinski J.: Clinical significance of MSH2 gene
mutation carrier – status in family suspected of hereditary predisposition to
non-polyposis colorectal cancer. Acta Endoscopica Polona 1996; 3: 139-143
(Polish).
10. Kladny J., Lubinski J.: Hereditary non-polyposis colorectal cancer. Pol. Przegl.
Chir. 1996; 68: 728-734 (Polish).
11. Kladny J., Lubinski J.: Sub-total colectomy with prophylactic resection of
uterus and adnexis in a patient with asymptomatichereditary non-polyposis
colorectal cancer. Pol. Przegląd Chir. 1996; 68: 712-714 (Polish).
1
12. Kladny J., Zajaczek S., Lubinski J.: Increased Constitutional Sensitivity to
Bleomycin in Patients with Hereditary Non-Polyposis Colorectal Cancer. J.
Appl.Genet.1996; 37: 385-392.
13. Lubinski J., Zajaczek S., Kladny J., Kurzawski G., Menkiszak J., Hadaczek P.,
Cybulski C., Krzystolik K., Toloczko A., Podolski J., Gronwald J.: Hereditary
tumours - prophylactics, early diagnosis, treatment. Biotechnologia 1996; 4:
201-207.
1997
14. Gronwald J., Storkel S., Holtgreve-Grez H., Hadaczek P., Brinkschmidt Ch.,
Jauch A., Lubinski J.: Comparison of DNA Gains and Losses in Primary Renal
Clear Cell Carcinomas and Metastatic Sites; Cancer Research 1997; 57: 481487.
15. Kladny J., Bielicki D., Flicinski J., Marlicz K., Lubinski J.: Colonoscopies in
asymptomatic patients from families suspected of hereditary non-polyposis
colorectal cancer. Gastroenterologia Polska 1997; 4: 277-283 (Polish).
16. Kladny J., Lubinski J.: Clinical features of hereditary non-polyposis colorectal
cancers in material of Hereditary Cancer Centre in Szczecin. Gastroenterologia
Polska 1997; 4: 267-275 (Polish).
17. Kladny J., Lubinski J.: Incidence of hereditary non-polyposis colorectal cancer
(HNPCC) in the city of Szczecin, north-west Poland. J. Appl. Genet. 1997; 38:
103-114.
18. Lubinski J., Zajaczek S., Kladny J., Kurzawski G., Podolski J., Toloczko A.,
Menkiszak J., Gronwald J., Krzystolik K., Hadaczek P.,: Hereditary tumours prophylactics, early diagnosis, treatment. Wspolczesna Onkologia 1997; 1: 5-8
(Polish).
19. Zajaczek S., Lubinski J.: Significance of cytogenetics in genetic counselling for
families with hereditary predispositions to tumours. Ginekol. Pol. 1997; S1:
170-184 (Polish).
1998
20. Gronwald J., Lubinski J., Zdziarska B.: Tamoxifen in chemoprevention of
hereditary breast cancer; Wspolcz. Onkol. 1998; 7: 183-184 (Polish).
21. Gronwald J., Menkiszak J., Toloczko A., Zajaczek S., Kladny J., Kurzawski G.,
Krzystolik K., Podolski J., Lubinski J.: Hereditary Breast Cancer; Pol. J. Pathol.
1998; 49: 59-66.
22. Hadaczek P., Siprashvili Z., Markiewski M., Domagala W., Druck T., McCue
P., Pekarsky Y., Ohta M., Huebner K., Lubinski J.: Absence or reduction of
Fhit expression in most clear cell renal carcinomas. Cancer Research 1998, 58:
2946-2951.
23. Kaczmarek-Kanold M., Zajaczek S., Fiszer-Maliszewska L., Lubinski J.: Longterm remission of acute myelogenous leukaemia as second tumour after
treatment of Wilm’s tumour; Ped. Polska 1998, 7: 233-235 (Polish).
24. Kardas I., Denis A., Babinska M., Gronwald J., Podolski J., Zajaczek S., Kram
A. Lubinski J. Limon J.: Translocation (X;1) (p11.2;q21) in a Papillary Renal
2
25.
26.
27.
28.
29.
30.
Cell Carcinoma in a 14-Year-Old Girl. Cancer Genet Cytogenet 1998, 101:159161.
Krzystolik K., Cybulski C., Lubinski J., Zajaczek S., Sochanska M., Toloczko
A., Psut G., Gorecka M., Wilk G., Paprzyski W., Sikorski A., Czernicki K.,
Slojewski M., Gliniewicz B., Krzystolik Z., Lubinski W., Starzycka-Bigaj E.,
Kostyk E., Prost M., Zdunek M., Omulecka A., Jaskolski J., KoraszewskaMatuszewska B., Chibowski D., Zalewska R., Haus O., Zasada K., Kojder I.,
Kaczor R., Slosarek J., Wlodarczyk E., Domanski Z., Malukiewicz G.,
Bidzinski J., Wysocka B., Limon J., Jozwiak J.: Early diagnosis of
asymptomatic kidney cancers in families with von Hippel-Lindau disease in
Poland. Urol. Pol. 1998; 51: 171-181 (Polish).
Krzystolik K., Cybulski C., Lubinski J.: Von Hippel-Lindau disease. Neurol.
Neuchir. Pol. 1998; 32: 1119- 1133 (Polish).
Kurzawski G., Zajaczek S., Gorski B., Cybulski C., Jakubowska A., Lubinski
J.: Molecular analyses of DNA and RNA in detection of hereditary
predispositions to tumours. Wspolczesna Onkologia 1998; 4: 16–20 (Polish).
Menkiszak J., Rzepka-Gorska I., Gronwald J., Kladny J., Podolski J., Zajaczek
S., Toloczko A., Lubinski J.: Hereditary Ovarian Cancer – a Guide for
Clinicians. Pol. J. Gyn. Investig 1998; 1: 99-106.
Zajaczek S., Fiszer Maliszewska L., Lubinski J.: Li-Fraumeni syndrome.
Wspolcz. Onkol. 1998; 5: 193-196 (Polish).
Zajaczek S., Jakubowska A., Kurzawski G., Krzystolik K., Lubinski J.: Age at
diagnosis to discriminate those patients for whom constitutional DNA
sequencing is appropriate in sporadic unilateral retinoblastoma. Eur. J. Cancer
1998; 34, 12: 1919-1921.
1999
31. Cybulski C., Krzystolik K., Lubinski J.: Gene symbol: VHL. Disease: Von
Hippel-Lindau syndrome; Hum Genet 1999; 104: 2: 194.
32. Cybulski C., Krzystolik K., Maher E.R., Richard S., Kurzawski G., Gronwald
J., Lubinski J.: Long polymerase chain reaction in detection of germline
deletions in the von Hippel-Lindau tumour suppressor gene; Hum Genet 1999;
105: 333-336.
33. Gawronska-Szklarz B., Lubinski J., Kladny J., Kurzawski G., Bielicki D.,
Wojcicki M., Sych Z., Musial H.D.: Polymorphism of GSTM1 gene in patients
with colorectal cancer and colonic polyps. Exp Toxic Pathol 1999; 51: 321-325.
34. Gronwald J., Menkiszak J., Huzarski T., Byrski T., Jakubowska A., Zajaczek
S., Toloczko A., Podolski J., Gorecka B., Zdziebkowska H., Stanislawski P.,
Stawicka M., Lubinski J.: Clinical genetic services for Familial Breast Cancer
in Poland; Disease Markers 1999: 15: 46.
35. Hadaczek P., Kovatich A., Gronwald J., Lubinski J., Huebner K., McCue P.A.:
Loss or Reduction of Fhit expression in renal neoplasias: correlation with
histogenic class; Hum Path 1999; 30: 11: 1276-1283.
36. Jakubowska A., Gorski B., Kurzawski G., Kladny J., Lubinski J.: Gene symbol:
MLH1. Disease: Colorectal cancer, non-polyposis; Hum Genet 1999; 105: 3:
293.
3
37. Jakubowska A., Gronwald J., Huzarski T., Byrski T., Menkiszak J., Lubinski J.:
Gene symbol: BRCA2. Disease: Breast cancer; Hum Genet 1999; 105: 3: 293.
38. Kurzawski G., Kladny J., Debniak T., Lubinski J.: Gene Symbol: MLH1.
Disease: Colorectal cancer, non-polyposis. Hum Genet 1999, 105, 1-2: 189.
39. Kurzawski G.: Human Gene Mutations. Gene symbol: MSH2. Disease:
Colorectal cancer, non-polyposis; Hum Genet 1999; 104: 1: 116.
40. Menkiszak J., Gronwald J., Jakubowska A., Huzarski T., Byrski T., RzepkaGorska I., Lubinski J.: Hereditary ovarian cancer – summarisation of 6-year
experience. Nowotwory 1999; 49, Supl. 2: 9-12.
41. Park J.G., Vasen HF., Park K.J., Peltomaki P., Ponz de Leon M., RodriguezBigas, Lubinski J., Beck NE., Bisgaard ML., Miyaki M., Wijnen JT., Baba S.,
Lynch HT.: Suspected hereditary nonpolyposis colorectal cancer: International
Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICGHNPCC) criteria and results of genetic diagnosis. Dis Colon Rectum 1999; 42:
710-5.
42. Westerman A.M., Entius M.M., Boor P.P., Koole R., de Baar E., Offerhaus
G.J., Lubinski J., Lindhout D., Halley D.J., de Rooij F.W., Wilson J.H.: Novel
mutations in the LKB1/STK11 gene in Dutch Peutz-Jeghers families. Hum.
Mut 1999; 13, 6: 476-481.
43. Zajaczek S., Cragg H., Jakubowska A., Gorski B., Krzystolik Z., Cowell J.K.,
Lubinski J.: Molecular analysis of a novel large constitutional deletion in
patient with retinoblastoma; J. Appl. Genet. 1999; 40: 233-239.
44. Zajaczek S., Jakubowska A., Gorski B., Kurzawski G., Krzystolik Z., Lubinski
J.: The First Promoter Rb-1 Germ-line de novo Mutation in Patient with
Sporadic Unilateral Retinoblastoma; J. Appl. Genet. 1999; 40: 241-247.
45. Zajaczek S., Lubinski J.: Rules of genetic counselling in families with increased
risk of cancer. Nowotwory 1999; 49: 83-87 (Polish).
46. Zajaczek S., Gorski B., Krzystolik Z., Lubinski J.: Constitutional Chromosome
Instability in Families with Patients Affected by Sporadic Non-Hereditary
Retinoblastomas. J. Appl. Genet. 1999; 40: 343-353.
47. Zajaczek S., Jakubowska A., Gorski B., Kurzawski G., Krzystolik Z., Lubinski
J.: Frequency and nature of germ-line Rb-1 gene mutations in a series of
patients with sporadic unilateral retinoblastoma. Eur. J. Cancer, 1999; 35, 13:
1824-1827.
2000
48. Debniak T., Kurzawski G., Gorski B., Kladny J., Domagala W., Lubinski J.:
Value of pedigree/clinical data, immunochemistry and microsatellite instability
analyses in reducing the cost of determining hMLH1 and hMSH2 gene
mutations in patients with colorectal cancer. Eur J. Cancer 2000; 36: 49-54.
49. Gorski B., Byrski T., Huzarski T., Jakubowska A., Menkiszak J., Gronwald J.,
Pluzanska A., Bebenek M., Fischer-Maliszewska L., Grzybowska E., Narod
S.A., Lubinski J.: Founder Mutations in the BRCA1 Gene in Polish Families
with Breast-Ovarian Cancer. Am. J. Hum. Genet. 2000; 66: 1963-1968.
50. Lubinski J., Gorski B., Kurzawski G., Jakubowska A., Debniak T., Cybulski C.,
Byrski T., Huzarski T., Kladny J., Zajaczek S., Gronwald J., Menkiszak J.,
4
Krzystolik K., Hadaczek P., Huzarska J.: Genetics in early diagnosis of
tumours. Wspolczesna Onkologia 2000; 4, 5: 186-189 (Polish).
51. Lubinski J., Gorski B., Kurzawski G., Jakubowska A., Debniak T., Cybulski C.,
Byrski T., Huzarski T., Kladny J., Zajaczek S., Gronwald J., Menkiszak J.,
Krzystolik K., Hadaczek P., Huzarska J.: Molecular analyses in diagnosis of
high genetic predisposition to tumours. Onkol. Pol. 2000, 3, 2: 93-97 (Polish).
52. Lubinski J., Gorski B., Kurzawski G., Jakubowska A., Debniak T., Cybulski C.,
Byrski T., Huzarski T., Kladny J., Zajaczek S., Gronwald J., Menkiszak J.,
Krzystolik K., Hadaczek P., Huzarska J.: Molecular analyses in diagnosis of
high genetic predisposition to malignancies, J Clin Biochem Nutr. 2000, 28,
159-165.
53. Haites N., Moeslein G., Neumann H., Lubinski J., Sobol H., Ponder B., Pharoah
P., Vasen H., Weber W.: Standards of diagnosis and treatment in families with
high genetic predisposition to tumours; Medycyna po Dyplomie 2000, Special
Edition – December, 160 (Polish).
2001
54. De los Rios P., Jack E., Kuperstein G., Lynch H., Lubinski J., Narod S.A.:
Founder mutations of BRCA1 and BRCA2 in North American families of
Polish origin that are affected with breast cancer. Am J Hum Genet 2001, Feb
68 (2): 546.
55. Debniak T., Gorski B., Cybulski C., Jakubowska A., Kurzawski G., Kladny J.,
Lubinski J.: Comparison of Alu-PCR, microsatellite instability, and
immunohistochemical analyses in finding features characteristic for hereditary
nonpolyposis colorectal cancer; J Cancer Res Clin Oncol 2001; 127: 565-569.
56. Druck T., Podolski J., Byrski T., Wyrwicz L., Zajaczek S., Kata G., Borowka
A., Lubinski J., Huebner K.: The DIRC1 gene at chromosome 2q33 spans a
familial RCC-associated t(2;3) (q33,q21) chromosome translocation; J Hum
Genet 2001; 46: 583-589.
57. Hadaczek P., Debniak T., Kurzawski G., Jakubowska A., Huzarski T., Huebner
K., Lubinski J.: Fhit Protein Expression in Hereditary and Sporadic Colorectal
Cancers; Pol J Pathol 2001, 53: 3: 125-132.
58. Jakubowska A., Gorski B., Byrski T., Huzarski T., Gronwald J., Menkiszak J.,
Cybulski C., Debniak T., Hadaczek P., Scott RJ., Lubinski J.: Detection of
Germline Mutations in the BRCA1 Gene by RNA-Based Sequencing. Hum
Mut 2001, 18: 149-156.
59. Jakubowska A., Gorski B., Kurzawski G., Debniak T., Hadaczek P., Cybulski
C., Kladny J., Oszurek O., Scott R.J., Lubinski J.: Optimisation of
Experimental Conditions for RNA-Based Sequencing of MLH1 and MSH2
Genes. Hum Mut 2001, 17: 52-60.
60. Jakubowska A., Zajaczek S., Haus O., Limon J., Kostyk E., Krzystolik Z.,
Lubinski J.: Novel RB1 gene constitutional mutations found in Polish patients
with familial and/or bilateral retinoblastoma. Hum Mut 2001; 18(5): 459.
61. Kurzawski G., Debniak T., Kladny J., Lubinski J.: Age at diagnosis of cancer
as predistor of mutation occurrence in families suspected of HNPCC; J. Appl.
Genet. 2001; 42(3): 359-366.
5
62. Lubinski W., Zajaczek S., Sych Z., Penkala K., Palacz O., Lubinski J.:
Electrooculogram in patients with neurofibromatosis type 1; Documenta
Ophthalmologica 2001; 103: 91-103.
63. Oszurek O., Gorski B., Gronwald J., Prosolow Z., Uglanica K., Murinow A.,
Bobko I., Downar O., Zlobicz M., Norik D., Byrski T., Jakubowska A.,
Lubinski J.: Founder mutations in the BRCA1 gene in west Belarusian breastovarian cancer families; Clinical Genetics 2001; 60 (6): 470-471.
64. Hadaczek P., Gronwald J., Chosia M., Huebner K., Lubinski J.: Fhit protein
expression in endometrial cancers: no correlation with histological grade; Pol J
Pathol 2001: 54: 4: 199-203.
65. Muller W, Burgart LJ, Krause-Paulus R, Thibodeau SN, Almeido M,
Edmonston TB, Boland CR, Sutter C, Jass JR, Lindblom A, Lubinski J,
MacDermont K, Sanders DSA, Morreau H, Muller A, Oliani C, Orntoft T, Pond
De Leon M, Rosty C, Rodrigues-Bigas M, Ruschoff J, Ruszkiewicz A, Sabarrin
J, Moeslein G: The reliability of immunohistochemistry as a prescreening
method for the diagnosis of hereditary nonpolyposis colorectal cancer
(HNPCC) - results of an international collaborative study, Familial Cancer,
2001: 1: 87-92.
66. Podolski J., Byrski T., Zajaczek S., Druck T., Zimonjic D.B., Popescu N.C.,
Kata G., Borowka A., Gronwald J., Lubinski J., Huebner K.: Characterization
of a familial RCC-associated t(2;3)(q33;q21) chromosome translocation; J Hum
Genet 2001; 46 (12): 685-93.
2002
67. Gorski B., Jakubowska A., Huzarski T., Gronwald J., Byrski T., Stawicka M.,
Huzarska J., Menkiszak J., Kowalska E., Toloczko-Grabarek A., Zajacek S.,
Rzepka-Gorska I., Gorecka-Szyld B., Wilk G., Foszczynska-Kloda M., Ucinski
M., Debniak T., Kladny J., Medrek K., Masojc B., Mierzejewski M., Sieminska
M., Raczynski A., Blachowski M., Tarhoni M., Niepsuj S., Gozdz S., Bebenek
M., Fiszer-Maliszewska L., Pluzanska A., Haus O., Janiszewska H., Milczarek
S., Rawluk J., Limon J., Kupryjanczyk J., Kowalczyk J., Miturski R., Midro A.,
Zaremba L., Posmyk M., Szczylik C., Godlewski D., Urbanski K., Debniak B.,
Rozmiarek A., Koc J., Szwiec M., Czudowska D., Kilar E., Grabowska E.,
Lener M., Falinski R., Rogalska S., Kurzawski G., Suchy J., Cybulski C.,
Mackiewicz A., Grzybowska E., Lubinski J.: Progress in prophylactics,
diagnosis and treatment of tumours in BRCA1 mutation carriers; Nowotwory
2002 (Polish).
68. Kurzawski G., Safranow K., Suchy J., Chlubek, Lubinski J.: Mutation analysis
of MLH1 and MSH2 genes performed by using denaturing high performance
liquid chromatography; J Biochem and Biophys Methods 2002 Mar 4, 51 (1):
89-100.
69. Grabowski M, Huzarski T, Lubinski J, Sikorski A: Survival in patients with
rare subtypes of renal cell carcinoma, BJU Int 2002 Apr; 89 (6): 599-600.
70. Park JG, Vasen HF, Park YT, Park KJ, Peltomaki P, de Leon MP, RodriguezBigas MA, Lubinski J, Beck NE, Bisgaard ML, Miyaki M, Wijnen JT, Baba S,
Lindblom A, Madlensky L, Lynch HT: Suspected HNPCC and Amsterdam
6
71.
72.
73.
74.
75.
76.
77.
78.
7
criteria II: evaluation of mutation detection rate, an international collaborative
study, Int J Colorectal Dis, 2002 Mar; 17 (2): 109-14.
Lubinski W., Zajaczek S., Sych Z., Penkala K., Palacz O., Lubinski J.:
Electroretinographic changes in the inner retinal layer of the retained eyes of
patients with sporadic unilateral retinoblastoma; Ophthalmic Genet, 2002, Jan;
23 (2): 99-107.
Kurzawski G., Suchy J., Kladny J., Safranow K., Elsakov P., Kucinskas V.,
Gardovskis J., Irmejs A., Sibul H., Jakubowska A., Huzarski T., Byrski T.,
Debniak T., Cybulski C., Gronwald J., Clark J., Gozdz S., Niepsuj S., Slomski
R., Plawski A., Lacka-Wojciechowska A., Rozmiarek A., Fiszer-Maliszewska
L., Bebenek M., Sorokin D., Stawicka M., Godlewski D., Richter P., Limon J.,
Brozek I., Wysocka B., Jawien A., Banaszkiewicz Z., Kowalczyk J.,
Czudowska D., Debiec-Rychter M., Goretzki P.E., Moeslein G., Lubinski J.:
Germline MSH2 and MLH1 mutational spectrum in HNPCC families from
Poland and Baltic States, J Med. Genet 2002 Oct 39 (10): E65.
Sutter T, Dansranjavin T, Lubinski J, Debniak T, Giannakudis J, Hoang-Vu C,
Dralle H: Overexpression of cyclin E protein is closely related to the mutator
phenotype of colorectal carcinoma, Int J Colorectal Dis, 2002 Nov; 17 (6): 37480.
Cybulski C., Krzystolik K., Murgia A., Gorski B., Debniak T., Jakubowska A.,
Martella M., Kurzawski G., Prost M., Kojder I., Limon J., Nowacki P., Sagan
L., Bialas B., Kaluza J., Zdunek M., Omulecka A., Jaskolski D., Kostyk E.,
Koraszewska-Matuszewska B., Haus O., Janiszewska H., Pecold K., Starzycka
M., Slomski R., Cwirko M., Sikorski A., Gliniewicz B., Cyrylowski L., FiszerMaliszewska L., Gronwald J., Toloczko-Grabarek A., Zajaczek S., Lubinski J.:
Germline mutations in von Hippel-Lindau (VHL) gene in patients from Poland:
disease presentation in patients with deletions of the entire VHL gene; J Med
Genet 2002 Jul; 39 (7): E38.
Suchy J, Kurzawski G, Jakubowska A, Lubinski J: Ovarian cancer of
endometroid type as part of the MSH6 gene mutation phenotype, J Hum Genet.
2002; 47 (10): 529-31.
Lubinski J, Gorski B, Kurzawski G, Jakubowska A, Cybulski C, Suchy J,
Debniak T, Grabowska E, Lener M, Nej K: Molecular basis of inherited
predispositions for tumors, Acta Biochem Pol, 2002; 49 (3): 571-81.
Narod S.A., Dube MP, Klijn J, Lubinski J, Lynch HT, Ghadirian P, Provencher
D, Heimdal K, Moller P, Robson M, Offit K, Isaacs C, Weber B, Friedman E,
Gershoni-Baruch R, Rennert G, Pasini B, Wagner T, Daly M, Garber JE,
Neuhausen SL, Ainsworth P, Olsson H, Evans G, Osborne M, Couch F,
Foulkes WD, Warner E, Kim-Sing C, Olopade O, Tung N, Saal HM, Weitzel J,
Merajver S, Gauthier-Villars M, Jernstrom H, Sun P, Brunet JS: Oral
contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation
carriers, J Natl Cancer Inst, 2002 Dec 4; 94 (23): 1773-9.
Jakubowska A, Nej K., Huzarski T., Scott RJ, Lubinski J:: BRCA2 gene
mutations in families with aggregations of breast and stomach cancers, Br J
Cancer, 2002 Oct 7; 87 (8): 888-91.
79. Menkiszak J, Gorski B, Jakubowska A, Gronwald J, Huzarski T, Byrski T,
Foszczynska-Kloda M, Flicinski J, Brzosko M, Rzepka-Gorska I, Lubinski J.:
Clinical characteristics of hereditary ovarian cancer (HOC) in Poland, Ginekol
Pol. 2002 Sep; 73 (9): 733-9.
2003
80. Narod S., Lubinski J., Roles of radiation dose, chemotherapy, and hormonal
factors in breast cancer following Hodgkin's disease, J Natl Cancer Inst. 2003
Oct 15; 95 (20): 1552.
81. Gronwald J, Gorski B, Byrski T, Huzarski T, Jakubowska A, Menkiszak J,
Narod SA, Lubinski J.: Non-random transmission of mutant alleles to female
offspring of BRCA1 carriers in Poland, J Med Genet. 2003 Sep ; 40 (9): 71920.
82. Gorski B, Debniak T, Jakubowska A, Cybulski C, Huzarski T, Byrski T,
Zlowocka E, Lubinski J.: Usefulness of polymorphic markers in exclusion of
BRCA1/BRCA2 mutations in families with aggregation of breast/ovarian
cancers, J Appl Genet. 2003; 44 (3): 419-23.
83. Lubinski W, Kurzawski G, Suchy J, Szych Z, Penkala K, Palacz O, Scott RJ,
Lubinski J.: Electro-oculographic and electroretinographic studies in HNPCC
gene mutation carriers, Ophthalmic Res. 2003 Sep-Oct; 35 (5): 281-94.
84. Debniak T, Gorski B, Cybulski C, Jakubowska A, Kurzawski G, Lener M,
Mierzejewski M, Masojc B, Medrek K, Kladny J, Zaluga E, Maleszka R,
Chosia M, Lubinski J., Germline 657del5 mutation in the NBS1 gene in
patients with malignant melanoma of the skin, Melanoma Res. 2003 Aug; 13
(4): 365-70.
85. Gorski B, Debniak T, Masojc B, Mierzejewski M, Medrek K, Cybulski C,
Jakubowska A, Kurzawski G, Chosia M, Scott R, Lubinski J.: Germline
657del5 mutation in the NBS1 gene in breast cancer patients, Int J Cancer. 2003
Sep 1; 106 (3): 379-81. Erratum in: Int J Cancer. 2003 Oct 10; 106 (6): 984.
86. Debniak T, Gorski B, Cybulski C, Jakubowska A, Kurzawski G, Kladny J,
Zaluga E, Fiedorowicz J, Debniak B, Lubinski J., Increased risk of breast
cancer in relatives of malignant melanoma patients from families with strong
cancer familial aggregation, Eur J Cancer Prev. 2003 Jun; 12 (3): 241-5.
87. Jakubowska A, Narod SA, Goldgar DE, Mierzejewski M, Masojc B, Nej K,
Huzarska J, Byrski T, Gorski B, Lubinski J., Breast cancer risk reduction
associated with the RAD51 polymorphism among carriers of the BRCA1
5382insC mutation in Poland, Cancer Epidemiol Biomarkers Prev. 2003
May;12 (5): 457-9.
88. Lubinski W, Krzystolik K, Cybulski C, Szych Z, Penkala K, Palacz O, Lubinski
J.: Retinal function in the von Hippel-Lindau disease, Doc Ophthalmol. 2003
May; 106 (3): 271-80.
89. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman
N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles
DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J,
Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjakoski K,
Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton
8
90.
91.
92.
93.
94.
95.
96.
DF.: Average risks of breast and ovarian cancer associated with BRCA1 or
BRCA2 mutations detected in case Series unselected for family history: a
combined analysis of 22 studies, Am J Hum Genet. 2003 May; 72 (5): 1117-30.
Epub 2003 Apr 03. Erratum in: Am J Hum Genet. 2003 Sep;73 (3): 709.
Lubinski W., Gorski B., Szych Z., Penkala K., Palacz O., Lubinski J.:
Electroretinographic Changes In Eyes of Patients with BRCA1 Gene Mutation,
Ophthalmic Res 2003, 35: 164-169.
Kladny J., Moeslein G., Myrhoj T., Kurzawski G., Jakubowska A., Debniak T.,
Petriczko W., Kozlowski M., Amawi A., Flicinski T., Banaszkiewicz A.,
Richter P., Lubinski J.: Nuclear pedigree criteria of suspected HNPCC. Her Ca
in Clin Pract 2003, 1: 34-38.
Irmejs A., Gardovskis A, Borosenko V, Bitina M, Aigare D, Kurzawski G,
Suchy J, Gorski B, Gardovskis J. Hereditary Colorectal Cancer (CRC)
Programm in Latvia, Her Ca in Clin Pract 2003, 1: 49-53.
Jakubowska A., Scott R., Menkiszak J., Gronwald J., Byrski T., Huzarski T.,
Górski B., Cybulski C., Dębniak T., Kowalska E., Starzyńska T., Ławniczak
M., Narod S., Lubiński J.: A High Frequency of BRCA2 Gene Mutations in
Polish Families with Ovarian and Stomach Cancer. Eur J Hum Genet, 2003
Dec; 11 (12): 955-958
Lynch HT, Lynch JF, Shaw TG, Lubinski J: HNPCC (Lynch Syndrome):
Differential Diagnosis, Molecular Genetics and Management - a Review, Her
Ca in Clin Pract, 2003, 1: 7-18..
Menkiszak J, Gronwald J, Gorski B, Jakubowska A, Huzarski T, Byrski T,
Foszczyńska-Kłoda M, Haus O, Janiszewska H, Perkowska M, Brożek I,
Grzybowska E, Zientek H, Góźdź S, Kozak-Klonowska B, Urbański K,
Miturski R, Kowalczyk J, Płużańska A, Niepsuj S, Koc J, Szwiec M, Drosik K,
Mackiewicz A, Lamperska K, Stróżyk E, Godlewski D, Stawicka M, Waśko B,
Bębenek M, Rozmiarek A, Rzepka-Górska I, Narod SA, Lubiński J, Hereditary
Ovarian Cancer in Poland, Int J Cancer 2003, 106, 942-945.
Janiszewska H, Haus O, Lauda-Swieciak A, Pasinska M, Laskowski R,
Szymanski W, Gorski B, Lubinski J. Frequency of three BRCA1 gene founder
mutations in breast/ovarian cancer families from the Pomerania-Kujawy region
of Poland. Clin Genet. 2003 Dec; 64 (6): 502-8.
2004
97. Kurzawski G, Suchy J, Kladny J, Grabowska E, Mierzejewski M, Jakubowska
A, Debniak, Cybulski C, Kowalska E, Szych Z, Domagala W, Scott RJ,
Lubinski J, The NOD2 3020insC mutation and the risk of colorectal cancer,
Cancer Research, 2004, 64, March 1, 64 (5): 1604-6.
98. Dębniak T, Górski B, Cybulski C, Kurzawski G, Złowocka E, Kładny J, Chosia
M, Lubiński J,: Rarity of germline 1100delC mutation in CHEK2 in patients
with malignant melanoma of the skin, Mel Res, 2004, Apr; 14 (2): 121-4.
99. Menkiszak J, Gronwald J, Gorski B, Byrski T, Huzarski T, Jakubowska A,
Foszczynska-Kloda M, Brzosko M, Flicinski J, Rzepka-Gorska I, Narod SA,
Lubinski J.: Clinical features of familial ovarian cancer lacking mutations in
BRCA1 or BRCA2, Eur J Gynaecol Oncol. 2004; 25 (1): 99-100.
9
100. Cybulski C, Gorski B, Debniak T, Gliniewicz B, Mierzejewski M, Masojc B,
Jakubowska A, Matyjasik J, Zlowocka E, Sikorski A, Narod SA, Lubinski J:
NBS1 is a prostate cancer susceptibility gene, Cancer Research 2004, Feb 15;
64 (4): 1215-9.
101. Pławski A, Lubiński J, Banasiewicz T, Paszkowski J, Lipiński D, Strembalska
A, Kurzawski G, Byrski T, Zajączek S, Hodorowicz-Zaniewska D, Gach T,
Brożek I, Nowakowska D, Czkwaniec E, Krokowicz P, Drews M, Zeyland J,
Juzwa W, Słomski R. Novel germline mutations in the adenomatous polyposis
coli gene in Polish families with familial adenomatous polyposis. J Med Genet.
2004 Jan; 41 (1): e11.
102. Rzewuska-Lech E, Lubiński J. Breast Cancer and Estrogen, Her Can Clin Pract
2004, 2 (1): 33-38.
103. Królewska K, Jakubowska A, Zajączek S. Breast Cancers with Ocular
Metastases are Early Onset, Non-Familial and Non-BRCA1/BRCA2 Tumours,
Her Can Clin Pract 2004, 2 (1): 47-48.
104. Ghadirian P, Lubinski J, Lynch H, Neuhausen SL, Weber B, Isaacs C, Baruch
RG, Randall S, Ainsworth P, Freidman E, Horsman D, Tonin P, Foulkes WD,
Tung N, Sun P, Narod SA: Smoking and the risk of breast cancer among
carriers of BRCA mutation, Int J Cancer 2004, 110 (3): 413-6.
105. Cybulski C, Huzarski T, Gorski B, Masojc B, Mierzejewski M, Debniak T,
Gliniewicz B, Matyjasik J, Zlowocka E, Kurzawski G, Sikorski A, Posmyk M,
Szwiec M, Czajka R, Narod SA, Lubinski J: A novel founder CHEK2 mutation
is associated with increased prostate cancer risk, Cancer Res 2004, 64 (8):
2677-9.
106. Menkiszak J, Rzepka-Gorska I, Gorski B, Byrski T, Huzarski T, Jakubowska A,
Foszczynska-Kloda M, Brzosko M, Flicinski J, Rzepka-Gorska I, Narod SA,
Lubinski J: Attitudes toward preventive oophorectomy among BRCA1
mutation carriers in Poland, Eur J Gynaecol Oncol 2004, 25 (1): 93-5.
107. Menkiszak J, Brzosko M, Gorski B, Flicinski J, Jakubowska A, Zebielowicz D,
Gronwald J, Huzarski T, Byrski T, Teresinski L, Chosia M, Rzepka-Gorska I,
Lubinski J. Ovarian cystadenoma as a characteristic feature of families with
hereditary ovarian cancers unassociated with BRCA1 and BRCA2 mutations. J
Appl Genet. 2004; 45 (2): 255-63.
108. Debniak T, Gorski B, Scott RJ, Cybulski C, Medrek K, Zlowocka E, Kurzawski
G, Debniak B, Kladny J, Bielecka-Grzela S, Maleszka R, Lubinski J. Germline
mutation and large deletion analysis of the CDKN2A and ARF genes in
families with multiple melanoma or an aggregation of malignant melanoma and
breast cancer. Int J Cancer. 2004 Jul 1; 110 (4): 558-62.
109. Gawdis-Wojnarska B, Brzosko M, Flicinski J, Marlicz K, Starzynska T, Scott
RJ, Lubinski J. Nuclear Pedigree Criteria for the Identification of Individuals
Suspected to be at Risk of an Inherited Predisposition to Gastric Cancer, Her
Can Clin Pract 2004, 2 (2): 65-68.
110. Cybulski C, Matyjasik J, Soroka M, Szymaś J, Górski B, Dębniak T,
Jakubowska A, Bernaczyk A, Zimnoch L, Bierzyńska–Macyszyn G,
Trojanowski T, Wierzba-Bobrowicz T, Prudlak E, Markowska–Wojciechowska
A, Nowacki P, Roszkiewicz A, Kordek R, Szylberg T, Matyja E, Zieliński K,
10
111.
112.
113.
114.
115.
116.
117.
118.
119.
11
Woźniewicz B, Taraszewska A, Kozłowski W, Lubiński J. Mutations in the von
Hippel-Lindau Tumour Suppressor Gene in Central Nervous System
Hemangioblastomas, Her Can Clin Pract 2004, 2 (2): 93-97.
Jernstrom H, Lubinski J, Lynch HT, Ghadirian P, Neuhausen S, Isaacs C,
Weber B, Horsman D, Rosen B, Foulkes WD, Friedman E, Gershoni-Baruch R,
Ainsworth P, Daly M, Garber J, Olsson H, Sun P, Narod SA. Breast-feeding
and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers, J Natl
Cancer Inst. 2004 Jul 21; 96 (14): 1094-8.
Gorski B, Jakubowska A, Huzarski T, Byrski T, Gronwald J, Grzybowska E,
Mackiewicz A, Stawicka M, Bebenek M, Sorokin D, Fiszer-Maliszewska L,
Haus O, Janiszewska H, Niepsuj S, Gozdz S, Zaremba L, Posmyk M, Pluzanska
M, Kilar E, Czudowska D, Wasko B, Miturski R, Kowalczyk JR, Urbanski K,
Szwiec M, Koc J, Debniak B, Rozmiarek A, Debniak T, Cybulski C, Kowalska
E, Toloczko-Grabarek A, Zajaczek S, Menkiszak J, Medrek K, Masojc B,
Mierzejewski M, Narod SA, Lubinski J. A high proportion of founder BRCA1
mutations in Polish breast cancer families. Int J Cancer. 2004 Jul 10; 110 (5):
683-6.
Lubinski J, Phelan CM, Ghadirian P, Lynch HT, Garber J, Weber B, Tung N,
Horsman D, Isaacs C, Monteiro AN, Sun P, Narod SA. Cancer variation
associated with the position of the mutation in the BRCA2 gene. Fam Cancer.
2004; 3 (1): 1-10.
Misiewicz I, Skupinska K, Kowalska E, Lubinski J, Kasprzycka-Guttman T:
Sulforaphane-mediated induction of a phase 2 detoxifying enzyme
NAD(P)H:quinone reductase and apoptosis in human lymphoblastoid cells,
Acta Biochim Pol. 2004; 51 (3): 711-21.
Gronwald J, Jauch A, Cybulski C, Schoell B, Bohm-Steuer B, Lener M,
Grabowska E, Gorski B, Jakubowska A, Domagala W, Chosia M, Scott RJ,
Lubinski J. Comparison of genomic abnormalities between BRCAX and
sporadic breast cancers studied by comparative genomic hybridization, Int J
Cancer. 2004 Nov 11 [Epub].
Cybulski C, Gorski B, Huzarski T, Masojc B, Mierzejewski M, Debniak T,
Teodorczyk U, Byrski T, Gronwald J, Matyjasik J, Zlowocka E, Lenner M,
Grabowska E, Nej K, Castaneda J, Medrek K, Szymanska A, Szymanska J,
Kurzawski G, Suchy J, Oszurek O, Witek A, Narod SA, Lubinski J. CHEK2 Is
a Multiorgan Cancer Susceptibility Gene, Am J Hum Genet. 2004 Dec;
75(6):1131-5. Epub 2004 Oct 18.
Gorski B, Menkiszak J, Gronwald J, Lubinski J, Narod SA.: A protein
truncating BRCA1 allele with a low penetrance of breast cancer. J Med Genet.
2004 Dec; 41 (12): e130.
Kurzawski G, Suchy J, Debniak T, Kladny J, Lubinski J.: Importance of
microsatellite instability (MSI) in colorectal cancer: MSI as a diagnostic tool,
Ann Oncol. 2004; 15 Suppl 4: iv283-4.
Debniak T: Familial malignant melanoma – overview, Her Can Clin Pract
2004, 2 (3): 123-130.
120. Nej K, Bartsch DK, Sina-Frey M, Rieder H, Hahn SA, Lubinski J: The NOD2
3020insC Mutation and The Risk of Familial Pancreatic Cancer? Her Can Clin
Pract 2004, 2 (3): 149-150.
121. Lubinski W, Zajaczek S, Sych Z, Penkala K, Palacz O, Lubinski J:
Supernormal Electro-Oculograms in Patients with Neurofibromatosis Type 1,
Her Can Clin Pract 2004, 2 (4): 193-196.
2005
122. Huzarski T, Lener M, Domagala W, Gronwald J, Byrski T, Kurzawski G,
Suchy J, Chosia M, Woyton J, Ucinski M, Narod SA, Lubinski J.: The
3020insC allele of NOD2 predisposes to early-onset breast cancer. Breast
Cancer Res Treat. 2005 Jan; 89 (1): 91-3.
123. Debniak T, Scott RJ, Huzarski T, Byrski T, Rozmiarek A, Debniak B, Zaluga
E, Maleszka R, Kladny J, Gorski B, Cybulski C, Gronwald J, Kurzawski G,
Lubinski J.: CDKN2A common variants and their association with melanoma
risk: a population-based study. Cancer Res. 2005 Feb 1; 65 (3): 835-9.
124. Gronwald J, Jauch A, Cybulski C, Schoell B, Bohm-Steuer B, Lener M,
Grabowska E, Gorski B, Jakubowska A, Domagala W, Chosia M, Scott RJ,
Lubinski J.: Comparison of genomic abnormalities between BRCAX and
sporadic breast cancers studied by comparative genomic hybridization. Int J
Cancer. 2005 Mar 20; 114 (2): 230-6.
125. Huzarski T, Cybulski C, Domagala W, Gronwald J, Byrski T, Szwiec M,
Woyke S, Narod SA, Lubinski J. Pathology of breast cancer in women with
constitutional CHEK2 mutations. Breast Cancer Res Treat. 2005 Mar; 90 (2):
187-9.
126. Misiewicz I, Kozar A, Skupinska K, Kowalska E, Lubinski J, KasprzyckaGuttman T. Inhibition of cell cycle and induction of apoptosis by sulforaphane
in cell lines carrying various inherited BRCA1 mutations. Oncol Rep. 2005
Apr; 13 (4): 659-65.
127. Debniak T, Kurzawski G, Huzarski T, Byrski T, Gronwald J, Debniak B,
Rozmiarek A, Dziuba I, Zlowocka E, Suchy J, Gorski B, Cybulski C,
Mierzejewski M, Masojc B, Medrek K, Oszurek O, Lubinski J. NOD2 variants
and the risk of malignant melanoma. Eur J Cancer Prev. 2005 Apr; 14 (2): 1436.
128. Kardas I, Mrozek K, Babinska M, Krajka K, Hadaczek P, Lubinski J,
Roszkiewicz A, Kuziemska E, Limon J. Cytogenetic and molecular findings in
75 clear cell renal cell carcinomas. Oncol Rep. 2005 May; 13 (5): 949-56.
129. Kowalska E, Narod SA, Huzarski T, Zajaczek S, Huzarska J, Gorski B,
Lubinski J: Increased Rates of Chromosome Breakage in BRCA1 Carriers are
Reduced by Oral Selenium Supplementation, Cancer Epidemiol Biomarkers
Prev. 2005 May; 14 (5): 1302-6.
130. Lubiński J, Huzarski T, Kurzawski G, Suchy J, Masojć B, Mierzejewski M,
Lener M, Domagała W, Chosia M, Teodorczyk U, Mędrek K, Dębniak T,
Złowocka E, Gronwald J, Byrski T, Grabowska E, Nej K, Szymańska A,
Szymańska J, Matyjasik J, Cybulski C, Jakubowska A, Górski B, Narod SA,
12
131.
132.
133.
134.
135.
136.
137.
138.
139.
13
The 3020insC Allele of NOD2 Predisposes to Cancers of Multiple Organs,
Hereditary Cancer in Clinical Practice 2005; 3(2), 59-63.
Gardovskis A, Arvids Irmejs, Edvins Miklasevics, Viktors Borosenko,
Marianna Bitina, Inga Melbarde-Gorkusa, Andrejs Vanags, Grzegorz
Kurzawski, Janina Suchy, Bohdan Górski, Janis Gardovskis, Clinical,
Molecular and Geographical Features of Hereditary Breast/Ovarian Cancer in
Latvia, Hereditary Cancer in Clinical Practice 2005; 3(2), 71-76.
Debniak T, Gorski B, Huzarski T, Byrski T, Cybulski C, Mackiewicz A,
Gozdecka-Grodecka S, Gronwald J, Kowalska E, Haus O, Grzybowska E,
Stawicka M, Swiec M, Urbanski K, Niepsuj S, Wasko B, Gozdz S, Wandzel P,
Szczylik C, Surdyka D, Rozmiarek A, Zambrano O, Posmyk M, Narod S,
Lubinski J. A Common Variant of CDKN2A (p16) Predisposes to Breast
Cancer, J Med Genet. 2005 May 6; [Epub ahead of print]
Kurzawski M, Drozdzik M, Suchy J, Kurzawski G, Bialecka M, Gornik W,
Lubinski J. Polymorphism in the P-glycoprotein drug transporter MDR1 gene
in colon cancer patients, Eur J Clin Pharmacol. 2005 May 24; [Epub ahead of
print].
Kuokkanen M, Butzow R, Rasinpera H, Medrek K, Nilbert M, Malander S,
Lubinski J, Jarvela I. Lactase persistence and ovarian carcinoma risk in Finland,
Poland and Sweden, Int J Cancer. 2005 May 4; [Epub ahead of print]
Antoniou AC, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Olsson
H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang
N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B,
Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjakoski K, Kallioniemi
OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF. Breast and
ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and
BRCA2 6174delT mutations: a combined analysis of 22 population based
studies. J Med Genet. 2005 Jul; 42 (7): 602-3.
Gronwald J, Byrski T, Huzarski T, Narod SA, Lubinski J. Transmission of
mutant alleles to female offspring of BRCA1 carriers in Poland. J Med Genet.
2005 Jul; 42 (7): e40.
Cullinane CA, Lubinski J, Neuhausen SL, Ghadirian P, Lynch HT, Isaacs C,
Weber B, Moller P, Offit K, Kim-Sing C, Friedman E, Randall S, Pasini B,
Ainsworth P, Gershoni-Baruch R, Foulkes WD, Klijn J, Tung N, Rennert G,
Olopade O, Couch F, Wagner T, Olsson H, Sun P, Weitzel JN, Narod SA.
Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2
mutation carriers. Int J Cancer. 2005 Jun 28; [Epub ahead of print]
Gorski B, Cybulski C, Huzarski T, Byrski T, Gronwald J, Jakubowska A,
Stawicka M, Gozdecka-Grodecka S, Szwiec M, Urbanski K, Mitus J, Marczyk
E, Dziuba J, Wandzel P, Surdyka D, Haus O, Janiszewska H, Debniak T,
Toloczko-Grabarek A, Medrek K, Masojc B, Mierzejewski M, Kowalska E,
Narod SA, Lubinski J. Breast cancer predisposing alleles in Poland. Breast
Cancer Res Treat. 2005 Jul; 92 (1): 19-24.
Nkondjock A, Ghadirian P, Kotsopoulos J, Lubinski J, Lynch H, Kim-Sing C,
Horsman D, Rosen B, Isaacs C, Weber B, Foulkes W, Ainsworth P, Tung N,
Eisen A, Friedman E, Eng C, Sun P, Narod SA. Coffee consumption and breast
cancer risk among BRCA1 and BRCA2 mutation carriers. Int J Cancer. 2005
Jul 19; [Epub ahead of print]
140. Kotsopoulos J, Lubinski J, Lynch HT, Neuhausen SL, Ghadirian P, Isaacs C,
Weber B, Kim-Sing C, Foulkes WD, Gershoni-Baruch R, Ainsworth P,
Friedman E, Daly M, Garber JE, Karlan B, Olopade OI, Tung N, Saal HM,
Eisen A, Osborne M, Olsson H, Gilchrist D, Sun P, Narod SA. Age at menarche
and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Cancer
Causes Control. 2005 Aug; 16 (6): 667-674.
141. Kotsopoulos J, Lubinski J, Neuhausen SL, Lynch HT, Rosen B, Ainsworth P,
Moller P, Ghadirian P, Isaacs C, Karlan B, Sun P, Narod SA., Hormone
replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2
mutation carriers, Gynecol Oncol. 2005 Aug 30; [Epub].
142. Kotsopoulos J, Olopado OI, Ghadirian P, Lubinski J, Lynch HT, Isaacs C,
Weber B, Kim-Sing C, Ainsworth P, Foulkes WD, Eisen A, Sun P, Narod SA.
Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2
mutation carriers. Breast Cancer Res. 2005; 7(5): R833-43, 2005 Aug 19
[Epub].
14